Coherus Oncology Inc

Nyitva

SzektorEgészségügy

1.49

Áttekintés

Árfolyamváltozás megosztása

24 óra

Jelenlegi

Minimum

1.48

Maximum

1.55

Fő mutatók

By Trading Economics

Bevétel

-279M

-38M

Értékesítés

-438K

12M

P/E

Szektor átlag

3.509

50.958

Egy részvényre jutó nyereség

-0.25

Profit margin

-308.197

Munkavállalók

145

EBITDA

9.3M

-34M

Ajánlások

By TipRanks

Ajánlások

Erős vétel

12 hónapos előrejelzés

+442.76% upside

Osztalékok

By Acuity

Következő eredményjelentés

2026. aug. 6.

Piaci statisztika

By TradingEconomics

Piaci kapitalizáció

-31M

228M

Előző nyitás

1.49

Előző zárás

1.49

Hangulat hírek alapján

By Acuity

50%

50%

141 / 342 Rangsor szerint Healthcare

Coherus Oncology Inc Chart

A múltbeli teljesítmény nem megbízható mutatója a jövőbeli eredményeknek.

Kapcsolódó hírek

2026. jún. 25. 23:51 UTC

News

Crude oil prices rise amid escalating Middle East tensions after a projectile strike near Oman. The United States Oil Fund LP is slightly higher after hours.

2026. jún. 25. 23:51 UTC

Social Media
Correlated Moves
News

Qualcomm is in talks to acquire Modular for $4 billion. Shares are trading lower after the company's optimistic revenue targets and Investor Day updates.

2026. jún. 25. 23:51 UTC

Social Media
News

Micron Technology Inc. shares fell in after-market trading despite a 350% year-over-year revenue increase, amid broader tech sector weakness.

2026. jún. 25. 23:42 UTC

News
Macro News
ETF Constituents

The Vanguard Information Technology ETF rose in after-market trading, boosted by Micron's strong earnings and revenue forecast, despite mixed broader market sentiment.

2026. jún. 25. 23:41 UTC

ETF Constituents
Social Media
News
Correlated Moves

SPDR S&P 500 ETF Trust trades higher after market close, supported by positive returns from top holdings like Microsoft and Apple amid mixed market sentiment.

2026. jún. 25. 23:41 UTC

News
ETF Constituents
Social Media

Invesco QQQ Trust Series I rises in after-market hours, supported by a gain in the Nasdaq 100. Microsoft, Apple, and Meta contributed positively to performance.

2026. jún. 25. 23:41 UTC

News
Social Media

Apple Inc. has raised prices for its MacBook and iPad models due to higher memory and storage costs. Shares are advancing in after-market trading.

2026. jún. 25. 23:41 UTC

Social Media
News

Microsoft shares are higher in after-market trading following Thursday's close. Analysts are cautious amid rising console storage costs and AI spending concerns.

2026. jún. 25. 23:26 UTC

News
ETF Constituents
Social Media

Vanguard Growth ETF shares advanced in after-market trading, supported by gains from Microsoft, Apple, and Meta, following four sessions of declines.

2026. jún. 25. 23:22 UTC

News

Tesla's energy division may drive growth amid EV market challenges. Shares traded roughly flat during after-market hours following Thursday's close.

2026. jún. 25. 23:06 UTC

ETF Constituents
News

The SPDR Dow Jones Industrial Average ETF Trust is higher in after-market trading, supported by positive economic data and contributions from Microsoft and Goldman Sachs.

2026. jún. 25. 20:07 UTC

News
Macro Event
Correlated Moves

The USD/SEK exchange rate is lower today, influenced by upward revisions in US GDP growth and personal spending figures.

2026. jún. 25. 20:07 UTC

News

Starbucks shares are lower despite reports of U.S. sales growth and upgraded earnings guidance. The stock pulled back from earlier session highs amid broader market dynamics.

2026. jún. 25. 20:07 UTC

Macro Event
News

Positive U.S. macroeconomic indicators lift USD/NOK, which is trading higher since Wednesday's close and remains near the upper end of its one-month range.

2026. jún. 25. 20:07 UTC

Macro Event
News

The USD/CZK exchange rate remains roughly flat, influenced by recent U.S. economic reports, including an upward revision of Q1 GDP growth to 2.1%.

2026. jún. 25. 20:07 UTC

Correlated Moves
News
Macro Event

The USD/PLN is trading lower today, influenced by recent U.S. economic data and a slight decline in the US Dollar Index.

2026. jún. 25. 20:07 UTC

News
Macro Event
Correlated Moves

The USD/HUF exchange rate is lower today, reflecting a slight decline since Wednesday. U.S. macroeconomic data contributed to recent volatility in the currency pair.

2026. jún. 25. 20:07 UTC

Correlated Moves
Macro Event
News

The USD/DKK exchange rate is declining, influenced by upward revisions in US GDP growth and muted responses to personal income and spending data.

2026. jún. 25. 20:07 UTC

News
Correlated Moves

The GBP/HKD exchange rate is rising, supported by an increase in GBP/USD amid ongoing inflation concerns and geopolitical tensions in the Strait of Hormuz.

2026. jún. 25. 20:07 UTC

News
Correlated Moves

Ethereum is lower today, influenced by Bitcoin's decline. It remains below its 20-day moving average and has finished lower for three consecutive sessions.

2026. jún. 25. 20:07 UTC

Correlated Moves
Macro Event
News

Bitcoin is lower today, impacted by the expiration of $10 billion in options and geopolitical tensions. Ethereum also declines, reflecting similar market conditions.

2026. jún. 25. 20:07 UTC

Macro Event
News
Correlated Moves

Bitcoin is lower today, driven by the expiration of $10 billion in options and geopolitical tensions following an attack in the Strait of Hormuz.

2026. jún. 25. 20:06 UTC

News

The Nikkei 225 Index is higher in after-market hours, supported by earlier gains and remaining above its 20-day moving average. No specific news was identified.

2026. jún. 25. 19:56 UTC

ETF Constituents
News
Correlated Moves

Vanguard Real Estate ETF is higher as Simon Property Group and Welltower contribute positively, despite uncertainty from the postponed housing affordability bill.

2026. jún. 25. 19:56 UTC

News
Macro Event
Social Media

Geopolitical tensions from an attack on a cargo ship have pressured U.S. Treasury yields, contributing to a decline in the iShares 20+ Year Treasury Bond ETF.

2026. jún. 25. 19:46 UTC

Correlated Moves
News

Ethereum is trading lower amid persistent inflation and geopolitical tensions affecting oil supply. The asset remains below its 20-day moving average.

2026. jún. 25. 19:26 UTC

News

Sirius XM Holdings Inc. is lower amid mixed US market performance and declines in major tech stocks, reflecting profit-taking and valuation concerns.

2026. jún. 25. 19:16 UTC

Correlated Moves
News

The U.S. core PCE price index rose in May, suggesting ongoing inflation. The Vanguard Mortgage-Backed Securities ETF is trading higher since Wednesday's close.

2026. jún. 25. 19:16 UTC

Macro Event
Correlated Moves
News

The Vanguard Total Bond Market ETF is higher today, supported by rising inflation data and an upward revision in Q1 GDP growth, reflecting stronger economic activity.

2026. jún. 24. 23:56 UTC

News
Correlated Moves

Ethereum is trading lower during Wednesday's session, reflecting broader market trends as Bitcoin also declines. The cryptocurrency remains below its 20-day moving average.

Társak összehasonlítása

Árváltozás

Coherus Oncology Inc Előrejelzés

Célár

By TipRanks

442.76% elmozdulás felfelé

12 hónapos előrejelzés

Átlag 8.25 USD  442.76%

Magas 12 USD

Alacsony 4 USD

5 Wall Street elemző 12 hónapos célárain alapulva a(z)Coherus Oncology Inc termékhez az elmúlt 3 hónapban.

Értékelési konszenzus

By TipRanks

Erős vétel

5 ratings

5

Vétel

0

Tartás

0

Eladás

Hangulat

By Acuity

141 / 342 Rangsor szerint Egészségügy

Hangulat hírek alapján

Neutral

Volatilitás

Átlag alatti

Hírmennyiség (RCV)

Átlag alatti

Pénzügyek

Értékesítési és adminisztrációs költségek

Üzemeltetési költségek

Adózás előtti nyereség

Értékesítés

Értékesítési költség

Értékesítési bruttó nyereség

Kamatköltség a hitelre

EBITDA

Üzemi nyereség

$

Rólunk Coherus Oncology Inc

Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of cancer treatments primarily in the United States. The company develops UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte-colony stimulating factor; LOQTORZI, a novel PD-1 inhibitor; and Casdozokitug, an investigational recombinant human immunoglobulin isotype G1 (IgG1) monoclonal antibody targeting interleukin 27. It is also developing CHS-114, an investigational highly specific human afucosylated IgG1 monoclonal antibody selectively targeting CCR8, a chemokine receptor highly expressed on Treg cells in the tumor microenvironment (TME); and CHS-1000, an antibody targeting human ILT4 designed to improve anti-PD-1 clinical benefit by transforming an unfavorable TME to a more favorable TME. In addition, the company's licensed immuno-oncology programs include NZV930, an antibody designed to inhibit cluster of differentiation 73; and GSK4381562, an antibody targeting CD112R for the treatment of solid tumors. Further, it offers YUSIMRY, a biosimilar to Humira for the treatment of patients with inflammatory diseases characterized by increased production of tumor necrosis factor (TNF) in the body, including rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, psoriasis, and ulcerative colitis. It collaboration agreement with Junshi Biosciences for the co-development and commercialization of toripalimab; agreement with Surface and Adimab LLC; license agreements with Bioeq AG and Genentech, Inc., as well as Vaccinex, Inc.; and out-licensing agreement with Novartis Institutes for Biomedical Research, Inc. and GlaxoSmithKline Intellectual Property No. 4 Limited. The company was formerly known as BioGenerics, Inc. and changed its name to Coherus BioSciences, Inc. in April 2012. Coherus BioSciences, Inc. was incorporated in 2010 and is headquartered in Redwood City, California.
help-icon Live chat